CD44 and breast carcinoma: In addition, the HER2-STAT3 network has been shown to contribute to the aggressive phenotype of breast cancer stem cells [20], and the JAK2/STAT3 signaling pathway is required for the growth of CD44+CD24− stem cell-like breast cancer cells in human tumors [21].